ATC code C

ATC code C Cardiovascular system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC.[5]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C Cardiovascular system
C01 Cardiac therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral vasodilators
C05 Vasoprotectives
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the renin–angiotensin system
C10 Lipid modifying agents

References

  1. ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ↑ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ↑ "ATC/DDD Index 2022: code C". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ↑ "ATCvet Index 2022: code QC". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.